Toxicology of pharmaceutical and nutritional longevity compounds.

Anti-aging compounds astaxanthin caffeine curcumin fucoxanthin metformin rapamycin resveratrol spermidine α-lipoic acid

Journal

Expert reviews in molecular medicine
ISSN: 1462-3994
Titre abrégé: Expert Rev Mol Med
Pays: England
ID NLM: 100939725

Informations de publication

Date de publication:
22 06 2023
Historique:
medline: 19 9 2023
pubmed: 22 6 2023
entrez: 22 6 2023
Statut: epublish

Résumé

Aging is the most prominent risk factor for many diseases, which is considered to be a complicated biological process. The rate of aging depends on the effectiveness of important mechanisms such as the protection of DNA from free radicals, which protects the structural and functional integrity of cells and tissues. In any organism, not all organs may age at the same rate. Slowing down primary aging and reaching maximum lifespan is the most basic necessity. In this process, it may be possible to slow down or stabilise some diseases by using the compounds for both dietary and pharmacological purposes. Natural compounds with antioxidant and anti-inflammatory effects, mostly plant-based nutraceuticals, are preferred in the treatment of age-related chronic diseases and can also be used for other diseases. An increasing number of long-term studies on synthetic and natural compounds aim to elucidate preclinically and clinically the mechanisms underlying being healthy and prolongation of life. To delay age-related diseases and prolong the lifespan, it is necessary to take these compounds with diet or pharmaceuticals, along with detailed toxicological results. In this review, the most promising and utilised compounds will be highlighted and it will be discussed whether they have toxic effects in short/long-term use, although they are thought to be used safely.

Identifiants

pubmed: 37345424
doi: 10.1017/erm.2023.18
pii: S1462399423000182
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e28

Auteurs

Cigdem Kahraman (C)

Department of Pharmacognosy, Hacettepe University Faculty of Pharmacy, Ankara, Turkey.

Duygu Kaya Bilecenoglu (D)

Faculty of Health Sciences, Aydın Adnan Menderes University, Aydın, Turkey.

Suna Sabuncuoglu (S)

Department of Pharmaceutical Toxicology, Hacettepe University Faculty of Pharmacy, Ankara, Turkey.

Irem Tatli Cankaya (IT)

Department of Pharmaceutical Botany, Hacettepe University Faculty of Pharmacy, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH